-
Strategies for a discontinuous future.












Tuesday, January 18, 2005
 


Genome Economy

The cost of gene synthesis is dropping exponentially, making mass production viable - a Moore's law for the biotech industry? The key driver is microfluidics - arrays which can synthesize genes in massive parallel at little cost. Synthetic Bio imho promises to be a truly disruptive technology - forget disk drives, think penicillin:

"...These results illustrate the potential of microfluidics-based ultra-fast oligonucleotide parallel synthesis as an enabling tool for modern synthetic biology such as construction of genome-scale vectors and cell free proteome protein expression. It is exciting to foresee one day protein libraries can be made as easily as libraries of small molecules so that the functions encoded in protein sequences can be fully explored to benefit human health and life."

Link to quote. Some microfluidics players: Fluidigm, Surface Logix, Caliper.

-- umair // 1:14 PM //


Comments:
Post a Comment
search



new


input

due diligence
ventureblog
a vc
techblurbs
tj's weblog
venture chronicles
terranova
the big picture
gigaom
venchar
bill burnham
babak nivi
n-c thoughts
paidcontent
techdirt
slashdot
london gsb
mefi
boingboing
blort
hardwax
betalounge

ing
morgan
chicago fed
dallas fed
ny fed
imf
world bank
nouriel roubini

portfolio
contact

mail.
uhaque (dot) mba2003 (at) london (dot) edu

skype.
umair.haque

atom feed

technorati profile

blog archives